Try our beta test site

Botulinum Toxin Injection Efficiency

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2009 by Jyväskylä Central Hospital.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
Eurostars
Information provided by:
Jyväskylä Central Hospital
ClinicalTrials.gov Identifier:
NCT01041157
First received: December 8, 2009
Last updated: December 30, 2009
Last verified: December 2009
  Purpose
The purpose of the study is to examine the effect of the botulinum toxin injection into muscle tone, strength and mobility with and without muscle exercise effect.

Condition Intervention Phase
Torticollis
Muscle Spasticity
Other: Resistance training
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effectiveness of Botulinum Toxin Injection After Exercising Splenius Capitis Muscle in Patients With Cervical Dystonia

Resource links provided by NLM:


Further study details as provided by Jyväskylä Central Hospital:

Primary Outcome Measures:
  • Muscle tone in splenius capitis muscle [ Time Frame: five months ]

Secondary Outcome Measures:
  • Pain in the neck [ Time Frame: five months ]
  • Mobility in the neck [ Time Frame: five months ]
  • Neck muscle strength [ Time Frame: five months ]

Estimated Enrollment: 22
Study Start Date: September 2008
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
resistance training
Other: Resistance training
Neck muscle trainings effect on botulinum toxin efficiency

Detailed Description:
The purpose is also to find out patients subjective symptoms between injections. Hypothesis: Efficiency of the botulinum toxin is more powerful with the muscle exercise before injection.
  Eligibility

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of cervical dystonia
  • Spasticity in splenius capitis muscle
  • Regular treatment with botulinum toxin injection

Exclusion Criteria:

  • Don't want to take part the Trial
  • Very long distance from home to Jyväskylä Central Hospital
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01041157

Locations
Finland
Central Finland Helth Care District
Jyväskylä, Finland
Sponsors and Collaborators
Jyväskylä Central Hospital
Eurostars
Investigators
Study Director: Jari Ylinen, MD, PhD Senior physician
  More Information

Responsible Party: Ylinen Jari, Jyvaskylä Central Hospital
ClinicalTrials.gov Identifier: NCT01041157     History of Changes
Other Study ID Numbers: KSKS 
Study First Received: December 8, 2009
Last Updated: December 30, 2009

Keywords provided by Jyväskylä Central Hospital:
Torticollis
Botulinum Toxins

Additional relevant MeSH terms:
Torticollis
Muscle Spasticity
Dystonic Disorders
Movement Disorders
Central Nervous System Diseases
Nervous System Diseases
Dystonia
Dyskinesias
Neurologic Manifestations
Signs and Symptoms
Muscular Diseases
Musculoskeletal Diseases
Muscle Hypertonia
Neuromuscular Manifestations
Botulinum Toxins
Acetylcholine Release Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Cholinergic Agents
Neurotransmitter Agents
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on February 24, 2017